Skip to content
MedsAcross

Medicine

Vasostrict 0.2 units/mL injection

Vasopressin, unspecified · Intravenous · Par Health
Available on requestPrescription onlyUS FDA Cold chain

Vasostrict 0.2 units/mL injection is a prescription medicine containing Vasopressin, unspecified for intravenous use, marketed by Par Health, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Do not freeze. Vials may be held up to 12 months upon removal from…

Key facts

Active ingredient (INN)
Vasopressin, unspecified
Brand
Vasostrict
Strength
0.2 units/mL
Dosage form
Injection
Route
Intravenous
Packs
10 vials
Marketing authorisation holder
Par Health
Manufacturer
Par Health
Origin register
US FDA, United States
Storage
Do not freeze. Vials may be held up to 12 months upon removal from refrigeration to room temperature storage conditions (20°C to 25°C [68°F to 77°F], USP Controlled Room Temperature), anytime within the labeled shelf life. Once removed from refrigeration, unopened vial should be marked to indicate the revised 12 month expiration date. Store between 2°C and 8°C (36°F and 46°F).
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 December 2021
Identifiers
RxCUI 313578, 1593738, 2103182 +7DailyMed set ID b1147beb-743e-4c62-8927-91192447f8b8NDC 42023-237Application NDA204485

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
10 vial in 1 carton / 100 mL in 1 vial42023-237-10Par Health15 December 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Vasopressin, unspecified

Clinical summary

Vasopressin, unspecified is a prescription medicine indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. It is available as injection for intravenous use. MedsAcross supplies Vasopressin, unspecified for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Vasopressin, unspecified

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Vasostrict 0.2 units/mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.